


| business Yiling Pharmaceutical Reports 52.75% YOY Growth in R&D Investment, Boosting the Company's High Quality Development PR Newswire Asia |
|
SHIJIAZHUANG, China Aug. 28, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) on Thursday published its semiannual report of 2020. In the reporting period, the Company registered business revenues of 4.487 billion RMB , a year-on-year growth of 50.
Posted: 2020-08-28 14:58:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.